Nominees chosen for 2023 Board of Directors election
Voting members will receive election materials in January 2023.
UNOS using a collaborative improvement model to increase DCD lung transplantation
29 lung transplant programs are participating in the project.
Simulated modeling results now available for continuous distribution of kidney and pancreas
Report evaluates and compares several potential scenarios, will inform committees in their work.
Exception pathway for heart device recalls approved by OPTN Board of Directors
The OPTN Board of Directors approved the modification to OPTN Policy 6.4: Adult and Pediatric Status Exceptions to be a permanent part of OPTN policy at their Dec. 5 board meeting.
7,000 organs tracked with UNOS Organ Tracking Service
30% of all OPOs use the UNOS Organ Tracking Service to monitor organs in transit.
Honoring my organ donors
I’m totally grateful and living a full life.
COVID-19 update: Dec. 9, 2022
Medicare Part B immunosuppressive drug benefit; AST releases joint statement on COVID-19 vaccines and transplant; National Institutes of Health (NIH) updates; CDC updates guidance on COVID-19 boosters
UNOS seeks better air transportation for lifesaving organs
Board Presidents and Interim CEO request meeting with DOT, HRSA, FAA and TSA to find paths for improvement.
New Medicare benefit available for kidney recipients
Beginning Jan. 1, 2023, this new benefit helps cover the costs for immunosuppressive drugs beyond 36 months after transplant for patients with ESRD.
UNOS CEO calls for expanded improvements in the organ donation and transplant field
Nonprofit leader acknowledges public concerns and seeks stakeholder collaboration during pivotal moment for the U.S. donation and transplantation community.